Allergy and Infectious Diseases Research in Georgia
Allergy and Infectious Diseases Research (93.855) awarded $817 million to recipients in Georgia in 468 grants from fiscal 2021 to 2025, 3.8% of the program's national total. Emory University received the most, $650 million.
- Awarded in Georgia$817 million
- Awards468
- Share of the program3.8%
- Rank among states9th of 52
- National total$22 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 232 | $185 million |
| FY 2022 | 214 | $210 million |
| FY 2023 | 221 | $137 million |
| FY 2024 | 236 | $137 million |
| FY 2025 | 215 | $147 million |
Recipients in Georgia
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Emory University | Colleges and universities | 282 | $650 million |
| University of Georgia Research Foundation, Inc. | Nonprofits | 106 | $84.9 million |
| Georgia State University Research Foundation Inc | Colleges and universities | 23 | $42.8 million |
| Georgia Tech Research Corp | Colleges and universities | 26 | $19.4 million |
| Moonlight Therapeutics, Inc. | Small businesses | 3 | $5.1 million |
| Kennesaw State University | Colleges and universities | 2 | $3.8 million |
| Augusta University Research Institute, Inc | Nonprofits | 5 | $3.0 million |
| Microbial Medical, Inc. | Small businesses | 1 | $1.5 million |
| The Corporation of Mercer University | Colleges and universities | 3 | $1.2 million |
| Inlighta Biosciences L.L.C. | Small businesses | 1 | $1.0 million |
Open opportunities under this program
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- Immune Tolerance Network (UM1 Clinical Trial Required)
- Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
- NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)
- Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
See all 93 on the program page
Questions people ask
How much Allergy and Infectious Diseases Research money goes to Georgia?
$817 million from fiscal 2021 to 2025, across 468 awards. Georgia ranks 9th of 52 states and territories for this program.
Who receives Allergy and Infectious Diseases Research money in Georgia?
The largest recipient is Emory University, with $650 million in 282 awards. Next are University of Georgia Research Foundation, Inc. and Georgia State University Research Foundation Inc.
Can organizations in Georgia apply now?
Yes, 93 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Allergy and Infectious Diseases Research in other states
Other large programs in Georgia
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- 1332 State Innovation Waivers
- Children's Health Insurance Program
- Special Education Grants to States
- Temporary Assistance for Needy Families